NCT06625281 Effects of Epleys Maneuver Versus Semont-Plus Maneuver Combined with Brandt-Daroff Exercises on Dizziness and Quality of Life in Benign Paroxysmal Positional Vertigo
| NCT ID | NCT06625281 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Dizziness |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-07-20 |
| Primary Completion | 2024-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-07-20 with a primary completion date of 2024-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Vestibular hypofunction can result in symptoms consisting of dizziness, imbalance, and/or oscillopsia, gaze and gait instability, and impaired navigation and spatial orientation; thus, may negatively impact an individual\'s quality of life, and ability to perform activities of daily living. Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder which occurs with changing of the positions lying down, rolling over, climbing stairs, or looking up and down. The typical symptoms include dizziness, loss of balance, nystagmus, and nausea, limiting the daily activities of life and functional capacity. Much research has been done to rule out the prime treatment for posterior canal-BPPV using vestibular rehabilitation therapy (VRT), Canalith repositioning maneuvers (CRM), and habituation exercises, but scarce literature renders the combination of maneuvers and exercises. The current study will be used to determine and compare the effects of Epley\'s maneuver Versus the Semont-Plus maneuver combined with Brandt-Daroff exercises on Dizziness and Quality of life in participants with pc-Benign paroxysmal positional vertigo. The participants having clinically diagnosed Posterior canal Benign paroxysmal positional vertigo (BPPV) will be selected in this study. The outcome measure will be the Dizziness Handicap Inventory (DHI) to assess the Dizziness in participants and Vestibular activities and the participation measure (VAP) will assess the Quality of life. For such a randomized control trial a sample of 40 participants will be taken with 20 participants in each group will be included in the study. One group will undergo Epley's Maneuver and Brandt-daroff exercises and the second group will receive Semont-plus maneuver and Brandt-daroff exercises. Scores will be taken again after intervention. The study will be conducted over 1 year at Fauji Foundation Hospital and Foundation University Islamabad. Participants of interest would be approached and explained about the research. Informed written consent will be taken first. Recruited participants will be allocated to either of the groups through a convenient sampling method. All outcome measurements would be performed first at baseline and then after the 6 weeks intervention period..
Eligibility Criteria
Inclusion Criteria: * Both genders * Positive Dix Hallpike test. * Patients diagnosed with Posterior canal Benign Paroxysmal Positional Vertigo. * Patients with recurrent episodes of dizziness. * Age group 20-65. * Positive Dix Hallpike Test Exclusion Criteria: * Dix Hallpike test negative. * DHI Scale: 54+ Severe * Trauma * Ankylosing spondylitis * Cervical pathology-related dizziness * Spinal cord injury * Carotid stenosis * Other Vestibular pathologies (Meniere's disease, Vestibular hypofunction, Labyrinthitis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06625281 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Dizziness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06625281 currently recruiting?
Yes, NCT06625281 is actively recruiting participants. Contact the research team at marwaa.javed@gmail.com for enrollment information.
Where is the NCT06625281 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT06625281 clinical trial?
NCT06625281 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.